In critically ill patients, the small bowel permeability is increased, leading to bacterial translocation, and systemic inflammatory response syndrome. Plasma citrulline is a validated biomarker of functional enterocyte mass. Lipopolysaccharide (LPS) is a part of Gram negative bacteria, and plasma LPS concentration is a biomarker of bacterial translocation. The link between plasma citrulline and LPS in the critically ill is unknown. Investigators hypothesize that patients presenting with low plasma citrulline concentration, with presumed altered small bowel function, would have an increased phenomenon of bacterial translocation, and increased plasma LPS concentration. Investigators aimed to evaluate the link between plasma citrulline and LPS concentrations in critically ill patients at the time of ICU admission.
Study Type
OBSERVATIONAL
Enrollment
120
Two blood samples will be taken at ICU admission
Centre Hospitalier Universitaire de Besançon
Besançon, France
RECRUITINGPlasma citrulline concentration
biological assay
Time frame: Up to 12 hours after admission in the unit
plasma lipopolysaccharide concentration
biological assay
Time frame: Up to 12 hours after admission in the unit
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.